<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>health policy</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>health policy | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="Understanding the factors affecting global political priority for controlling sexually transmitted infections: a qualitative policy analysis
Authors: Wu, D.; Low, N.; Hawkes, S. J.
Score: 8.5, Published: 2023-10-03 DOI: 10.1101/2023.10.03.23296476
IntroductionSexually transmitted infections (STIs) are a significant public health challenge, but there is a perceived lack of political priority in addressing STIs as a global health issue. Our study aimed to understand the determinants of global political priority for STIs since the 1980s and to discern implications for future prioritisation.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/health-policy/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="health policy" />
<meta property="og:description" content="Understanding the factors affecting global political priority for controlling sexually transmitted infections: a qualitative policy analysis
Authors: Wu, D.; Low, N.; Hawkes, S. J.
Score: 8.5, Published: 2023-10-03 DOI: 10.1101/2023.10.03.23296476
IntroductionSexually transmitted infections (STIs) are a significant public health challenge, but there is a perceived lack of political priority in addressing STIs as a global health issue. Our study aimed to understand the determinants of global political priority for STIs since the 1980s and to discern implications for future prioritisation." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/health-policy/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2023-10-22T10:37:23+00:00" />
<meta property="article:modified_time" content="2023-10-22T10:37:23+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="health policy"/>
<meta name="twitter:description" content="Understanding the factors affecting global political priority for controlling sexually transmitted infections: a qualitative policy analysis
Authors: Wu, D.; Low, N.; Hawkes, S. J.
Score: 8.5, Published: 2023-10-03 DOI: 10.1101/2023.10.03.23296476
IntroductionSexually transmitted infections (STIs) are a significant public health challenge, but there is a perceived lack of political priority in addressing STIs as a global health issue. Our study aimed to understand the determinants of global political priority for STIs since the 1980s and to discern implications for future prioritisation."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "health policy",
      "item": "https://trxiv.yorks0n.com/posts/health-policy/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "health policy",
  "name": "health policy",
  "description": "Understanding the factors affecting global political priority for controlling sexually transmitted infections: a qualitative policy analysis\nAuthors: Wu, D.; Low, N.; Hawkes, S. J.\nScore: 8.5, Published: 2023-10-03 DOI: 10.1101/2023.10.03.23296476\nIntroductionSexually transmitted infections (STIs) are a significant public health challenge, but there is a perceived lack of political priority in addressing STIs as a global health issue. Our study aimed to understand the determinants of global political priority for STIs since the 1980s and to discern implications for future prioritisation.",
  "keywords": [
    
  ],
  "articleBody": " Understanding the factors affecting global political priority for controlling sexually transmitted infections: a qualitative policy analysis\nAuthors: Wu, D.; Low, N.; Hawkes, S. J.\nScore: 8.5, Published: 2023-10-03 DOI: 10.1101/2023.10.03.23296476\nIntroductionSexually transmitted infections (STIs) are a significant public health challenge, but there is a perceived lack of political priority in addressing STIs as a global health issue. Our study aimed to understand the determinants of global political priority for STIs since the 1980s and to discern implications for future prioritisation. MethodsThrough semi-structured interviews from July 2021 to February 2022, we engaged 20 key stakeholders (8 women, 12 men) from academia, United Nations agencies, international non-governmental organisations, philanthropic organisations, and national public health agencies. A published policy framework was employed for thematic analysis, and findings triangulated with relevant literature and policy documents. We examined issue characteristics, prevailing ideas, actor power dynamics and political contexts. ResultsA contrast in perspectives before and after the year 2000 emerged. STI control was high on the global health agenda during the late 1980s and 1990s, as a means to control HIV. A strong policy community agreed on evidence about the high burden of STIs and that STI management could reduce the incidence of HIV. The level of importance decreased when further research evidence did not find an impact of STI control interventions on HIV incidence. Since 2000, cohesion in the STI community has decreased. New framing for broad STI control has not emerged. Interventions that have been funded, such as human papillomavirus vaccination and congenital syphilis elimination have been framed as cancer control or improving newborn survival, rather than as STI control. ConclusionGlobally, the perceived decline in STI control priority might stem from discrepancies between investment choices and experts views on STI priorities. Addressing STIs requires understanding the intertwined nature of politics and empirical evidence in resource allocation. The ascent of universal health coverage presents an opportunity for integrated STI strategies but high-quality care sustainable funding and strategic coordination are essential. Key messages What is already know on this topic?{blacksquare} Setting priorities within health services is a political process. {blacksquare}Sexually transmitted infections (STIs) other than HIV are a significant public health issue. {blacksquare}STI control was high on the global health agenda in the late 1980s and 1990s, when it was promoted as a means to lower the transmission of HIV, but attention paid to STI control appears to have waned over the past two decades. What this study adds?{blacksquare} A range of factors, including but not limited to, empirical evidence of disease burden, have driven the attention paid to STI control over time. {blacksquare}The STI community has lacked cohesion, champions and engagement with civil society, thus contributing to their lowered position on health policy agendas. {blacksquare}STI control has been successful when framed as reaching aligned goals in other areas - HIV control, maternal and child health, cancer control - or when a biomedical intervention (vaccine, diagnostic) is available. How this study might affect research, practice or policy?{blacksquare} A more politically aware approach to STI control could increase policy attention and resource allocation, moving beyond technical evidence to understanding and leveraging political context. {blacksquare}The rollout of universal health coverage can present opportunities to integrate STI control into broader health policy reform and prioritisation, but the STI community will need to pay attention to issue-framing, community cohesion, and the role of policy entrepreneurs if they are to have success in forging a window of policy opportunity. {blacksquare}STI advocacy needs to be strengthened through strategic alliances with a diverse group of stakeholders, including civil society (e.g., those representing the broader sexual and reproductive health agenda and the cancer agenda).\nReal-world data: A systematic literature review on the barriers, challenges, and opportunities associated with their inclusion in the health technology assessment process\nAuthors: Zisis, K.; Pavi, E.; Geitona, M.; Athanasakis, K.\nScore: 0.8, Published: 2023-10-19 DOI: 10.1101/2023.10.18.23297151\nObjective: This systematic review aimed to assess the current use and acceptance of real-world data (RWD) and real-world evidence (RWE) in health technology assessment (HTA) process. It additionally aimed to discern stakeholders' viewpoints concerning RWD and RWE in HTA and illuminate the obstacles, difficulties, prospects, and consequences associated with the incorporation of RWD and RWE into the realm of HTA. Methods: A comprehensive PRISMA-based systematic review was performed in July 2022 in PubMed/Medline, Scopus, IDEAS-RePEc, International HTA database, and Centre for Reviews and Dissemination with ad-hoc supplementary search in Google Scholar and international organization websites. The review included pre-determined inclusion criteria while the selection of eligible studies, the data extraction process and quality assessment were carried out using standardized and transparent methods. Results: Twenty-nine (n=29) studies were included in the review out of 2.115 studies identified by the search strategy. In various global contexts, disparities in RWD utilization were evident, with randomized controlled trials (RCTs) serving as the primary evidence source. RWD and RWE played pivotal roles, surpassing relative effectiveness assessments (REAs) and significantly influencing decision-making and cost-effectiveness analyses. Identified challenges impeding RWD integration into HTA encompassed limited local data access, complexities in non-randomized trial design, data quality, privacy, and fragmentation. Addressing these is imperative for optimal RWD utilization. Incorporating RWD/RWE in HTA yields multifaceted advantages, enhancing understanding of treatment efficacy, resource utilization, and cost analysis, particularly via patient registries. RWE complements assessments of advanced therapy medicinal products (ATMPs) and rare diseases. Local data utilization strengthens HTA, bridging gaps when RCT data is lacking. RWD aids medical device decision-making, cancer drug reassessment, and indirect treatment comparisons. Challenges include data availability, stakeholder acceptance, expertise, and privacy. However, standardization, training, collaboration, and guidance can surmount these barriers, fostering enhanced RWD utilization in HTA. Conclusions: RWD and RWE are recognized as valuable when RCTs are lacking. Acceptance and use of RWD/RWE vary, with challenges including limited availability, methodological issues, expertise gaps, fragmentation, and data quality concerns. Addressing these barriers is crucial for effective utilization in HTA.\n",
  "wordCount" : "970",
  "inLanguage": "en",
  "datePublished": "2023-10-22T10:37:23Z",
  "dateModified": "2023-10-22T10:37:23Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/health-policy/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      health policy
    </h1>
    <div class="post-meta"><span>updated on October 22, 2023</span>

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.10.03.23296476">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.10.03.23296476" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.10.03.23296476">
        <p class="paperTitle">Understanding the factors affecting global political priority for controlling sexually transmitted infections: a qualitative policy analysis</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.10.03.23296476" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.10.03.23296476" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Wu, D.; Low, N.; Hawkes, S. J.</p>
        <p class="info">Score: 8.5, Published: 2023-10-03 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.10.03.23296476' target='https://doi.org/10.1101/2023.10.03.23296476'> 10.1101/2023.10.03.23296476</a></p>
        <p class="abstract">IntroductionSexually transmitted infections (STIs) are a significant public health challenge, but there is a perceived lack of political priority in addressing STIs as a global health issue. Our study aimed to understand the determinants of global political priority for STIs since the 1980s and to discern implications for future prioritisation.

MethodsThrough semi-structured interviews from July 2021 to February 2022, we engaged 20 key stakeholders (8 women, 12 men) from academia, United Nations agencies, international non-governmental organisations, philanthropic organisations, and national public health agencies. A published policy framework was employed for thematic analysis, and findings triangulated with relevant literature and policy documents. We examined issue characteristics, prevailing ideas, actor power dynamics and political contexts.

ResultsA contrast in perspectives before and after the year 2000 emerged. STI control was high on the global health agenda during the late 1980s and 1990s, as a means to control HIV. A strong policy community agreed on evidence about the high burden of STIs and that STI management could reduce the incidence of HIV. The level of importance decreased when further research evidence did not find an impact of STI control interventions on HIV incidence. Since 2000, cohesion in the STI community has decreased. New framing for broad STI control has not emerged. Interventions that have been funded, such as human papillomavirus vaccination and congenital syphilis elimination have been framed as cancer control or improving newborn survival, rather than as STI control.

ConclusionGlobally, the perceived decline in STI control priority might stem from discrepancies between investment choices and experts views on STI priorities. Addressing STIs requires understanding the intertwined nature of politics and empirical evidence in resource allocation. The ascent of universal health coverage presents an opportunity for integrated STI strategies but high-quality care sustainable funding and strategic coordination are essential.

Key messages What is already know on this topic?{blacksquare} Setting priorities within health services is a political process.
{blacksquare}Sexually transmitted infections (STIs) other than HIV are a significant public health issue.
{blacksquare}STI control was high on the global health agenda in the late 1980s and 1990s, when it was promoted as a means to lower the transmission of HIV, but attention paid to STI control appears to have waned over the past two decades.


What this study adds?{blacksquare} A range of factors, including but not limited to, empirical evidence of disease burden, have driven the attention paid to STI control over time.
{blacksquare}The STI community has lacked cohesion, champions and engagement with civil society, thus contributing to their lowered position on health policy agendas.
{blacksquare}STI control has been successful when framed as reaching aligned goals in other areas - HIV control, maternal and child health, cancer control - or when a biomedical intervention (vaccine, diagnostic) is available.


How this study might affect research, practice or policy?{blacksquare} A more politically aware approach to STI control could increase policy attention and resource allocation, moving beyond technical evidence to understanding and leveraging political context.
{blacksquare}The rollout of universal health coverage can present opportunities to integrate STI control into broader health policy reform and prioritisation, but the STI community will need to pay attention to issue-framing, community cohesion, and the role of policy entrepreneurs if they are to have success in forging a window of policy opportunity.
{blacksquare}STI advocacy needs to be strengthened through strategic alliances with a diverse group of stakeholders, including civil society (e.g., those representing the broader sexual and reproductive health agenda and the cancer agenda).</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.10.18.23297151">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.10.18.23297151" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.10.18.23297151">
        <p class="paperTitle">Real-world data: A systematic literature review on the barriers, challenges, and opportunities associated with their inclusion in the health technology assessment process</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.10.18.23297151" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.10.18.23297151" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Zisis, K.; Pavi, E.; Geitona, M.; Athanasakis, K.</p>
        <p class="info">Score: 0.8, Published: 2023-10-19 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.10.18.23297151' target='https://doi.org/10.1101/2023.10.18.23297151'> 10.1101/2023.10.18.23297151</a></p>
        <p class="abstract">Objective: This systematic review aimed to assess the current use and acceptance of real-world data (RWD) and real-world evidence (RWE)  in health technology assessment (HTA) process. It additionally aimed to discern stakeholders&#39; viewpoints concerning RWD and RWE in HTA and illuminate the obstacles, difficulties, prospects, and consequences associated with the incorporation of RWD and RWE into the realm of HTA.   Methods: A comprehensive PRISMA-based systematic review was performed in July 2022 in PubMed/Medline, Scopus, IDEAS-RePEc, International HTA database, and Centre for Reviews and Dissemination with ad-hoc supplementary search in Google Scholar and international organization websites. The review included pre-determined inclusion criteria while the selection of eligible studies, the data extraction process and quality assessment were carried out using standardized and transparent methods.   Results: Twenty-nine (n=29) studies were included in the review out of 2.115 studies identified by the search strategy. In various global contexts, disparities in RWD utilization were evident, with randomized controlled trials (RCTs) serving as the primary evidence source. RWD and RWE played pivotal roles, surpassing relative effectiveness assessments (REAs) and significantly influencing decision-making and cost-effectiveness analyses. Identified challenges impeding RWD integration into HTA encompassed limited local data access, complexities in non-randomized trial design, data quality, privacy, and fragmentation. Addressing these is imperative for optimal RWD utilization. Incorporating RWD/RWE in HTA yields multifaceted advantages, enhancing understanding of treatment efficacy, resource utilization, and cost analysis, particularly via patient registries. RWE complements assessments of advanced therapy medicinal products (ATMPs) and rare diseases. Local data utilization strengthens HTA, bridging gaps when RCT data is lacking. RWD aids medical device decision-making, cancer drug reassessment, and indirect treatment comparisons. Challenges include data availability, stakeholder acceptance, expertise, and privacy. However, standardization, training, collaboration, and guidance can surmount these barriers, fostering enhanced RWD utilization in HTA.   Conclusions: RWD and RWE are recognized as valuable when RCTs are lacking. Acceptance and use of RWD/RWE vary, with challenges including limited availability, methodological issues, expertise gaps, fragmentation, and data quality concerns. Addressing these barriers is crucial for effective utilization in HTA.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2023 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        Â· Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
